197 related articles for article (PubMed ID: 12472593)
1. Treatment of adult systemic mastocytosis with interferon-alpha: results of a multicentre phase II trial on 20 patients.
Casassus P; Caillat-Vigneron N; Martin A; Simon J; Gallais V; Beaudry P; Eclache V; Laroche L; Lortholary P; Raphaël M; Guillevin L; Lortholary O
Br J Haematol; 2002 Dec; 119(4):1090-7. PubMed ID: 12472593
[TBL] [Abstract][Full Text] [Related]
2. Interest of interferon alpha in systemic mastocytosis. The French experience and review of the literature.
Simon J; Lortholary O; Caillat-Vigneron N; Raphaël M; Martin A; Brière J; Barète S; Hermine O; Casassus P;
Pathol Biol (Paris); 2004 Jun; 52(5):294-9. PubMed ID: 15217717
[TBL] [Abstract][Full Text] [Related]
3. [Systemic mastocytosis].
Fain O; Stirnemann J; Eclache V; Barete S; Casassus P; Hermine O; Lorholary O
Presse Med; 2005 May; 34(9):681-7. PubMed ID: 15988348
[TBL] [Abstract][Full Text] [Related]
4. Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management.
Pardanani A
Am J Hematol; 2013 Jul; 88(7):612-24. PubMed ID: 23720340
[TBL] [Abstract][Full Text] [Related]
5. Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature.
Hauswirth AW; Simonitsch-Klupp I; Uffmann M; Koller E; Sperr WR; Lechner K; Valent P
Leuk Res; 2004 Mar; 28(3):249-57. PubMed ID: 14687620
[TBL] [Abstract][Full Text] [Related]
6. Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management.
Pardanani A
Am J Hematol; 2015 Mar; 90(3):250-62. PubMed ID: 25688753
[TBL] [Abstract][Full Text] [Related]
7. Treatment of three patients with systemic mastocytosis with interferon alpha-2b.
Worobec AS; Kirshenbaum AS; Schwartz LB; Metcalfe DD
Leuk Lymphoma; 1996 Aug; 22(5-6):501-8. PubMed ID: 8882964
[TBL] [Abstract][Full Text] [Related]
8. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide in systemic mastocytosis: results from an open-label, multicentre, phase II study.
Gruson B; Lortholary O; Canioni D; Chandesris O; Lanternier F; Bruneau J; Grosbois B; Livideanu C; Larroche C; Durieu I; Barete S; Sevestre H; Diouf M; Chaby G; Marolleau JP; Dubreuil P; Hermine O; Damaj G
Br J Haematol; 2013 May; 161(3):434-42. PubMed ID: 23432617
[TBL] [Abstract][Full Text] [Related]
10. Delineation of patterns of bone marrow mast cell infiltration in systemic mastocytosis: value of CD25, correlation with subvariants of the disease, and separation from mast cell hyperplasia.
Krokowski M; Sotlar K; Krauth MT; Födinger M; Valent P; Horny HP
Am J Clin Pathol; 2005 Oct; 124(4):560-8. PubMed ID: 16146815
[TBL] [Abstract][Full Text] [Related]
11. Response of severe systemic mastocytosis to interferon alpha.
Butterfield JH
Br J Dermatol; 1998 Mar; 138(3):489-95. PubMed ID: 9580806
[TBL] [Abstract][Full Text] [Related]
12. Indolent systemic mastocytosis: a case and review of the current available treatment options.
Lee Y; Wood P; Soyer HP
Dermatol Online J; 2013 Jun; 19(6):18562. PubMed ID: 24011312
[TBL] [Abstract][Full Text] [Related]
13. Interferon-α treatment in systemic mastocytosis.
Bjerrum OW
Curr Drug Targets; 2011 Mar; 12(3):433-6. PubMed ID: 21143153
[TBL] [Abstract][Full Text] [Related]
14. Mastocytosis: review of clinical and experimental aspects.
Hartmann K; Bruns SB; Henz BM
J Investig Dermatol Symp Proc; 2001 Nov; 6(2):143-7. PubMed ID: 11764303
[TBL] [Abstract][Full Text] [Related]
15. Aggressive systemic mastocytosis.
Inaoui R; Petit B; Jaccard A; Bertin P; Trèves R
Joint Bone Spine; 2003 Feb; 70(1):64-6. PubMed ID: 12639621
[TBL] [Abstract][Full Text] [Related]
16. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.
Sperr WR; Jordan JH; Fiegl M; Escribano L; Bellas C; Dirnhofer S; Semper H; Simonitsch-Klupp I; Horny HP; Valent P
Int Arch Allergy Immunol; 2002 Jun; 128(2):136-41. PubMed ID: 12065914
[TBL] [Abstract][Full Text] [Related]
17. Assessment of in vivo mast cell reactivity in patients with systemic mastocytosis.
Gülen T; Möller Westerberg C; Lyberg K; Ekoff M; Kolmert J; Bood J; Öhd J; James A; Dahlén SE; Nilsson G; Dahlén B
Clin Exp Allergy; 2017 Jul; 47(7):909-917. PubMed ID: 28258965
[TBL] [Abstract][Full Text] [Related]
18. Current approaches to the diagnosis and treatment of systemic mastocytosis.
Bains SN; Hsieh FH
Ann Allergy Asthma Immunol; 2010 Jan; 104(1):1-10; quiz 10-2, 41. PubMed ID: 20143640
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of systemic mastocytosis with high-dose interferon-alfa: long-term follow-up of a case.
Butterfield JH; Tefferi A; Kozuh GF
Leuk Res; 2005 Feb; 29(2):131-4. PubMed ID: 15607359
[TBL] [Abstract][Full Text] [Related]
20. Histamine metabolism in mastocytosis patients treated with interferon alpha-2b.
Granerus G; Lönnqvist B; Roupe G
Inflamm Res; 1996 Mar; 45 Suppl 1():S41-3. PubMed ID: 8696923
[No Abstract] [Full Text] [Related]
[Next] [New Search]
